[MDGL] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
01-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -9.93%
YoY- -55.86%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 0 0 0 0 0 1,354 3,360 -
PBT -3,379 -19,800 -22,286 -22,787 -14,620 -12,502 -9,074 -15.16%
Tax -110 0 0 0 0 0 30 -
NP -3,379 -19,800 -22,286 -22,787 -14,620 -12,502 -9,074 -15.16%
Tax Rate - - - - - - - -
Total Cost 3,379 19,800 22,286 22,787 14,620 13,856 12,434 -19.50%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -923.34 -270.06 -
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS -19.18 -5.24 -8.29 -11.55 -8.88 -9.15 -7.87 15.98%
EPS Diluted -19.18 -5.24 -8.29 -11.55 -8.88 -9.15 -7.87 15.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.